Effectiveness of Percutaneous Drainage on the Treatment of Mesh-Induced Seroma

dc.authoridOner, Serkan/0000-0002-7802-880X
dc.contributor.authorOner, Serkan
dc.contributor.authorAltay, Cetin Murat
dc.date.accessioned2024-09-29T16:09:41Z
dc.date.available2024-09-29T16:09:41Z
dc.date.issued2019
dc.departmentKarabük Üniversitesien_US
dc.description.abstractObjective: To investigate the effectiveness of percutaneous treatment of mesh-related seroma to salvage the mesh. Methods: Between October 2015 and December 2017, a total of four patients [three females, one male; mean age, 68.5 +/- 22 years (range, 61-83 years)] with repaired ventral hernia who underwent percutaneous drainage for the treatment of peri-mesh seroma were evaluated, retrospectively. In all patients, ultrasound was used to diagnose seroma and was the guiding imaging method during percutaneous procedures. General purpose pigtail-percutaneous drainage sets were used in all patients. Ethanol (96%) was used for sclerotherapy, and a fibrinolytic agent was used to destroy septa in multilocular collections. Laboratory investigations and comorbidities were evaluated in hospital data service, retrospectively. Mainly, the clinical success rates were evaluated, and technical success rates and procedure-related morbidity and mortality were also evaluated. Results: A total of 11 percutaneous drainage sessions (median, 2; range 1-6) were performed in four patients. The mean volume of fluid collections was 807.3 +/- 3006 cc (median, 291 cc; range, 114-3120 cc). There was no significant difference between the mesh sizes. A technical success rate was 100%. There was no procedure-related morbidity and mortality. The mean of the recurrence time of the peri-mesh seroma was 3.5 +/- 11 months (median, 2 months; range, 1-12 months). In all patients, during the follow-up, seroma was accumulated repetitively. Conclusion: Percutaneous treatment is an effective management option to salvage the mesh in patients with mesh-related seroma who are poor surgical candidates or whose mesh cannot be removed.en_US
dc.identifier.doi10.5152/EurJTher.2018.699
dc.identifier.endpage196en_US
dc.identifier.issn2564-7784
dc.identifier.issn2564-7040
dc.identifier.issue3en_US
dc.identifier.startpage193en_US
dc.identifier.trdizinid360291en_US
dc.identifier.urihttps://doi.org/10.5152/EurJTher.2018.699
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/360291
dc.identifier.urihttps://hdl.handle.net/20.500.14619/7715
dc.identifier.volume25en_US
dc.identifier.wosWOS:000486443100008en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofEuropean Journal of Therapeuticsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMesh-related seromaen_US
dc.subjectpercutaneous treatmenten_US
dc.subjectsalvage the meshen_US
dc.titleEffectiveness of Percutaneous Drainage on the Treatment of Mesh-Induced Seromaen_US
dc.typeArticleen_US

Dosyalar